Stocks and Investing
Stocks and Investing
Wed, October 26, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $325 on, Oct 26th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $321 to $325 on, Oct 26th, 2022.
Matthew has made no other calls on BIIB in the last 4 months.
There are 16 other peers that have a rating on BIIB. Out of the 16 peers that are also analyzing BIIB, 4 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Increased Target to $275 on, Friday, October 7th, 2022
- Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $275 on, Friday, September 30th, 2022
- Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $280 on, Wednesday, September 28th, 2022
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $217 on, Wednesday, September 28th, 2022
These are the ratings of the 12 analyists that currently disagree with Matthew
- Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $325 on, Monday, October 24th, 2022
- Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Held Target at $299 on, Thursday, October 13th, 2022
- Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Friday, October 7th, 2022
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $309 on, Thursday, October 6th, 2022
- Brian Skorney of "Baird" Upgraded from Hold to Buy and Increased Target to $340 on, Wednesday, September 28th, 2022
- Evan Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $360 on, Wednesday, September 28th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $350 on, Wednesday, September 28th, 2022
- Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $270 on, Wednesday, September 28th, 2022
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $265 on, Thursday, September 22nd, 2022
- Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $270 on, Thursday, July 21st, 2022
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $250 on, Thursday, July 21st, 2022
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $230 on, Monday, July 18th, 2022
Contributing Sources